Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -9.50 AUD. The highest annual figure on record is -9.50 AUD in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | -9.50 AUD | – |
| FY2024 | Jun 30, 2024 | -26.00 AUD | – |
| FY2023 | Jun 30, 2023 | -28.50 AUD | – |
| FY2022 | Jun 30, 2022 | -26.50 AUD | – |
| FY2021 | Jun 30, 2021 | -45.00 AUD | – |
| FY2020 | Jun 30, 2020 | -75.00 AUD | – |
| FY2019 | Jun 30, 2019 | -100.00 AUD | – |
| FY2018 | Jun 30, 2018 | -77.50 AUD | – |
| FY2017 | Jun 30, 2017 | -70.50 AUD | – |
| FY2016 | Jun 30, 2016 | -72.50 AUD | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?